🟢 Opus Genetics is trading 6.13% up in pre-market — no clear catalyst identified

Opus Genetics is trading 6.13% higher in pre-market at $4.50 on October 14, 2026, with no clear cause established by available reporting.

• The company is scheduled to present at Retina in Rio on October 14, including material related to the BIRD-1 study; the event listing alone does not confirm it drove the gain.
• The broader market is mixed, with no strong same-direction index move to explain the rise.